Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies

Clin Transl Radiat Oncol. 2020 Apr 24:23:30-34. doi: 10.1016/j.ctro.2020.04.009. eCollection 2020 Jul.

Abstract

Purpose: Recurrent head and neck cancers are associated with significant morbidity and mortality. Outcomes of multiple courses of radiation have not yet been described.

Methods and materials: A single institution database was queried to retrospectively review treatment plans and select patients who underwent ≥ 3 courses of radiation to the head and neck region.

Results: Thirty-three patients were found to have ≥ 3 courses of radiation with overlapping fields. Median local recurrence free survival after last course of reirradiation was 9.1 months and median overall survival was 10 months. Grade 3 and above toxicities were reported in 15 patients (45%). Grade 4 and above toxicities were reported in seven patients (21%). There was no grade 5 toxicity. 20 patients (61%) underwent subsequent therapies following completion of repeat reirradiation.

Conclusions: Repeat reirradiation to the head and neck region is feasible and carries significant risks that are most appropriately managed with a multi-disciplinary team and must be balanced against the potential for local control and opportunities for emerging systemic therapies.

Keywords: Head and neck malignancies; Radiation toxicity; Reirradiation; Salvage therapy.